Biomarker questions related to different mechanisms, such as T-cell activation through PD-1 inhibition versus macrophage repolarization through PSGL-1 inhibition, will need larger experiments to sample cancer diversity and may ideally be addressed in the clinic. Here, SELPLG is linked to cancer.